Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.
about
Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.Management of febrile neutropenia: ESMO Clinical Practice Guidelines.Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patientsLife-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia.Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy.Concise review: next-generation cell therapies to prevent infections in neutropenic patients.Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date.Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.Recurrent bowel-blood translocations of Escherichia coli with the unique virulence characteristics over three-year period in the patient with acute myeloid leukaemia - case report.Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis.Serum cortisol and inflammatory response in neutropenic fever.Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein.Serial plasma lactate measurements in haematological patients with neutropenic fever.Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome.Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia.Comprehensive detection of pathogens in immunocompromised children with bloodstream infections by next-generation sequencing.Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.
P2860
Q34543008-F55CB779-9984-43BF-903A-06FC40730005Q34620670-1CB2B2A9-0F6C-46CB-B0D8-D788AE3AA494Q34678894-D2B83E94-FB6E-4CD2-B98C-B260825DC49DQ35193767-0D27AAE1-4069-4A12-B443-BA5FA87E4FD5Q35814611-F9A05F3C-3A70-40D0-8EFD-A830C4DC7CF9Q36456366-E3DF6C08-E4CC-4ADB-986C-6D4D9D0B7FB8Q36709092-05676B91-3DD6-4695-B253-E50D409D5739Q37175053-532B1550-F7EE-4785-A46F-85B51DA72860Q38193653-05B3706A-B04D-48F8-8A82-2BD0A16CF46DQ38207933-63D5D007-9550-4B96-ABE2-8CA850F000D6Q38270780-38F48B7F-86A6-400B-9B21-7A7BA0688D12Q38952110-EB89AFF0-67FD-4586-9C74-28D895332A7AQ40225253-DDD17D14-67E7-4F0D-9AC9-C86FBBD96204Q40285684-9A709F24-ACD0-43F6-9CF2-B0048166F412Q40318466-02B2A397-7528-48CB-AA5F-CDC499A34054Q40329935-775DF265-335E-4202-8D0B-AA155FD2334CQ40358614-5108801E-CE01-4FEA-A4E7-8A30E570E496Q40375033-C5D537F7-E2BB-4348-ABC8-E20FEC40E638Q40407884-9661E07E-39A3-4B1D-9238-612326FD6CF2Q41530079-7DA6EB45-E393-40D8-839C-AA453B9E548EQ43984868-6E4F5EF6-4170-424A-8EA7-4204BAC6BB04Q47290687-239DF401-2282-440D-B221-5E0BA6EEC2A6Q52680661-E92C98EC-9B26-491F-883F-472DB20A6F24Q55092273-4AB3AD46-961D-4D1E-872C-6227D4BDA8F9
P2860
Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Neutropenic fever and severe s ...... rapy: Causes and consequences.
@en
type
label
Neutropenic fever and severe s ...... rapy: Causes and consequences.
@en
prefLabel
Neutropenic fever and severe s ...... rapy: Causes and consequences.
@en
P2093
P2860
P1433
P1476
Neutropenic fever and severe s ...... rapy: Causes and consequences.
@en
P2093
Esa Jantunen
Irma Koivula
Irma Matinlauri
Sari Hämäläinen
Tapio Nousiainen
Taru Kuittinen
P2860
P304
P356
10.1080/10428190701809172
P577
2008-03-01T00:00:00Z